Detalhe da pesquisa
1.
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Ann Hematol
; 102(2): 349-358, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564535
2.
Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK.
BMC Cancer
; 22(1): 735, 2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790913
3.
Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms.
Ann Hematol
; 101(12): 2655-2663, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269400
4.
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms.
Blood
; 134(21): 1832-1846, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511238
5.
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells.
Ann Hematol
; 100(12): 2943-2956, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34390367
6.
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia.
Mol Carcinog
; 59(1): 87-103, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31691359
7.
Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms.
Ann Hematol
; 98(12): 2703-2709, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31748924
8.
Adult hematopoietic stem cells lacking Hif-1α self-renew normally.
Blood
; 127(23): 2841-6, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060169
9.
Bosutinib: A Potent Second-Generation Tyrosine Kinase Inhibitor.
Recent Results Cancer Res
; 212: 87-108, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30069626
10.
Postoperative sugillations and necrosis.
J Dtsch Dermatol Ges
; 21(1): 74-76, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721926
11.
Postoperative Sugillationen und Nekrosen.
J Dtsch Dermatol Ges
; 21(1): 74-76, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721927
12.
Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance.
Blood
; 122(10): 1741-5, 2013 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23894152
13.
Concise review: genetic dissection of hypoxia signaling pathways in normal and leukemic stem cells.
Stem Cells
; 32(6): 1390-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24496882
14.
Evaluation of the clinical and prognostic importance of infection parameters in thyroid cancers: A cross-sectional study.
Medicine (Baltimore)
; 102(49): e36532, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38065882
15.
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling.
Front Oncol
; 13: 1277453, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941547
16.
Effects of covid-19 infection on thyroid functions.
J Med Biochem
; 41(4): 491-496, 2022 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36381073
17.
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Lancet Haematol
; 9(11): e810-e821, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328040
18.
Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms.
Blood Adv
; 5(17): 3373-3376, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34477817
19.
CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes.
Stem Cell Reports
; 16(11): 2768-2783, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34678208
20.
Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms.
Leukemia
; 34(4): 1062-1074, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31728053